Excelra-Astellas collaborates
Hyderabad’s Excelra, a leading Knowledge Solutions Company, has entered into a strategic Drug Repurposing collaboration with Tokyo-based pharmaceutical company, Astellas Pharma Inc.
The collaboration is focused on identifying novel therapeutic indications for a number of undisclosed Astellas’ shelved pharma assets.
Astellas will have access to Excelra’s proprietary Drug Repurposing Platform (GRIP), which is a combination of proprietary Repurposing Database, Repurposing Algorithms, Analytics tools and Visualization engine.
The collaboration offers a unique proposition to combine technology with scientific expertise in deciphering novel Mechanism of Actions using drug-disease-target relationships, to identify alternative indications for existing assets.
Astellas Pharma is dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. fii-news.com
